Mersana Therapeutics Inc
MRSN
Market Cap$407.58M
Close$
$-1.24
136.9% downside
Current Fair Value
136.9% downsideOvervalued by 136.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $407.58 Million |
|---|---|
| Enterprise Value | $232.13 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.48 |
| Beta | 1.53 |
| Outstanding Shares | 121,303,007 |
| Avg 30 Day Volume | 1,637,484 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.37 |
|---|---|
| PEG | 4.2 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.3 |
| Enterprise Value to EBIT | -1.36 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
ESG Score
No data
About Mersana Therapeutics Inc
CEO: Anna Protopapas